Calgary, Alberta—Dexmedetomidine offers anesthesiologists several potential analgesic options, but extending the duration of motor-sparing knee block may not be one of them, according to a new study.
Researchers at Western University, in London, Ontario, concluded that the addition of the alpha-2 agonist provided no additional benefits compared with similar blocks using adjuvant epinephrine in patients undergoing total knee arthroplasty.
“As we are all aware, total knee arthroplasty